The DOI matches its Crossref record; 113 of the 114 references it cites were found in a registry or an index.
The emerging role of HDL in glucose metabolism
Abstract
A low plasma level of HDL cholesterol is an atherosclerotic risk factor; however, emerging evidence suggests that low HDL levels might also contribute to the pathophysiology of type 2 diabetes mellitus (T2DM) through direct effects on plasma glucose. In the past decade, animal and clinical studies have uncovered a previously undescribed spectrum of HDL actions, indicating that HDL may control glucose homeostasis through mechanisms including insulin secretion, direct glucose uptake by muscle via the AMP-activated protein kinase, and possibly enhanced insulin sensitivity. These effects are mediated by multiple cell types via mechanisms including preservation of cell function through cellular lipid removal and also via direct signaling events. We suggest a paradigm shift from HDL being a bystander to being an active player in diabetic pathophysiology, which raises the possibility that HDL elevation could be a novel therapeutic avenue for T2DM. The entry of HDL-raising agents of the cholesteryl ester transfer protein (CETP) inhibitor class into late-phase clinical trials creates potential for rapid clinical translation. This Review will discuss the emerging evidence for a role of HDL-mediated glucose regulation in the pathophysiology of T2DM, and will also outline the therapeutic potential for HDL elevation for the prevention and management of T2DM.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This finding is consistent with previous mechanistic evidence linking CETP inhibition and HDL-C elevation to improved glucose metabolism [33,34].”
From Efficacy and safety of obicetrapib in patients with dyslipidemia: An updated meta-analysis of randomized controlled trials (2025) · cites this paper as [34]
Citations
Cites
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
A genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001282 · Cited by 2,837
Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.-P., & Colette, C. (2006) · JAMA · doi:10.1001/jama.295.14.1681 · Cited by 2,444
Statins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials
Sattar, N., Preiss, D., Murray, H. M., Welsh, P., Buckley, B. M., de Craen, A. J., Seshasai, S. R. K., McMurray, J. J., Freeman, D. J., Jukema, J. W., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61965-6 · Cited by 2,436
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis
Khera, A. V., Cuchel, M., de la Llera-Moya, M., Rodrigues, A., Burke, M. F., Jafri, K., French, B. C., Phillips, J. A., Mucksavage, M. L., Wilensky, R. L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1001689 · Cited by 1,943
Flagged first, then by citations
1 of the 114 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Clinical Update: Cardiovascular Disease in Diabetes Mellitus
Wang, C. C. L., Hess, C. N., Hiatt, W. R., & Goldfine, A. B. (2016) · Circulation · doi:10.1161/circulationaha.116.022194 · Cited by 1,222
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
Pirillo, A., Norata, G. D., & Catapano, A. L. (2013) · Cardiology · doi:10.1159/000346463 · Cited by 754
Li-ya, W., & Parhofer, K. G. (2014) · Metabolism · doi:10.1016/j.metabol.2014.08.010 · Cited by 543
Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia
Parhofer, K. G. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.5.353 · Cited by 458
HDL-targeted therapies: progress, failures and future
Kingwell, B. A., Chapman, M. J., Kontush, A., & Miller, N. E. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4279 · Cited by 354
Self-citationJaiswal, M., Divers, J., Dabelea, D., Isom, S., Bell, R. A., Martin, C. L., Pettitt, D. J., Saydah, S., Pihoker, C., Standiford, D. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-0179 · Cited by 303
Cardioprotective functions of HDLs
Rye, K., & Barter, P. J. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r039297 · Cited by 310
Self-citationThe role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk
Femlak, M., Gluba-Brzózka, A., Ciałkowska-Rysz, A. D., & Rysz, J. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0594-3 · Cited by 226
Are hypertriglyceridemia and low HDL causal factors in the development of insulin resistance?
Li, N., Fu, J., Koonen, D. P. Y., Kuivenhoven, J. A., Snieder, H., & Hofker, M. H. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.12.013 · Cited by 179
HDL Cholesterol and Risk of Type 2 Diabetes: A Mendelian Randomization Study
Haase, C. L., Tybjærg‐Hansen, A., Nordestgaard, B. G., & Frikke‐Schmidt, R. (2015) · Diabetes · doi:10.2337/db14-1603 · Cited by 162
Lipoprotein Particles and Incident Type 2 Diabetes in the Multi-Ethnic Study of Atherosclerosis
Mackey, R. H., Mora, S., Bertoni, A. G., Wassel, C. L., Carnethon, M. R., Sibley, C. T., & Goff, D. C. (2015) · Diabetes Care · doi:10.2337/dc14-0645 · Cited by 156
Soran, H., Hama, S., Yadav, R., & Durrington, P. N. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328355ca25 · Cited by 155
Lipidome as a predictive tool in progression to type 2 diabetes in Finnish men
Suvitaival, T., Bondia‐Pons, I., Yetukuri, L., Pöhö, P., Nolan, J. J., Hyötyläinen, T., Kuusisto, J., & Orešič, M. (2017) · Metabolism · doi:10.1016/j.metabol.2017.08.014 · Cited by 149
Nazir, S., Jankowski, V., Bender, G., Zewinger, S., Rye, K.-A., & van der Vorst, E. P. C. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.10.006 · Cited by 140
Self-citationHDL in Atherosclerotic Cardiovascular Disease: In Search of a Role
Casula, M., Colpani, O., Xie, S., Catapano, A. L., & Baragetti, A. (2021) · Cells · doi:10.3390/cells10081869 · Cited by 149
Trajkovska, K. T. (2017) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2017.7608 · Cited by 131
Abbasi, A., Corpeleijn, E., Gansevoort, R. T., Gans, R. O. B., Hillege, H. L., Stolk, R. P., Navis, G., Bakker, S. J. L., & Dullaart, R. P. F. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1680 · Cited by 128
The evolution of domain arrangements in proteins and interaction networks
Bornberg‐Bauer, E., Beaussart, F., Kummerfeld, S., Teichmann, S. A., & Weiner, J. M. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4416-1 · Cited by 127
Vallejo‐Vaz, A. J., Seshasai, S. R. K., Kurogi, K., Michishita, I., Nozue, T., Sugiyama, S., Tsimikas, S., Yoshida, H., & Ray, K. K. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.06.001 · Cited by 124
Reverse Engineering and Evaluation of Prediction Models for Progression to Type 2 Diabetes
ANDERSON, J. P., Parikh, J. R., Shenfeld, D. K., Ivanov, V., Marks, C., Church, B. W., Laramie, J. M., Mardekian, J., Piper, B. A., Willke, R. J., et al. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815620200 · Cited by 120
High-density lipoprotein, beta cells, and diabetes
von Eckardstein, A., & Widmann, C. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu143 · Cited by 105
Statins are diabetogenic – Myth or reality?
Sattar, N. A., & Taskinen, M. (2012) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2012.06.001 · Cited by 107
HDL endocytosis and resecretion
Röhrl, C., & Stangl, H. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.07.014 · Cited by 101
Zhang, N., Yang, X. T., Zhu, X., Zhao, B., Huang, T., & Ji, Q. (2017) · Journal of International Medical Research · doi:10.1177/0300060517693178 · Cited by 109
Quispe, R., Martin, S. S., & Jones, S. R. (2016) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000241 · Cited by 97
Babić, N., Valjevac, A., Začiragić, A., Avdagić, N., Zukić, S., & Hasić, S. (2019) · Medical Archives · doi:10.5455/medarh.2019.73.163-168 · Cited by 97
Beginning to Understand High-Density Lipoproteins
Santos‐Gallego, C. G., Badimon, J. J., & Rosenson, R. S. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2014.08.001 · Cited by 96
Macrophage Polarization: Implications on Metabolic Diseases and the Role of Exercise
Silveira, L. S., Antunes, B. M., Minari, A. L. A., dos Santos, R. V. T., Neto, J. C. R., & Lira, F. S. (2016) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukaryotgeneexpr.2016015920 · Cited by 96
HDL and glucose metabolism: current evidence and therapeutic potential
Siebel, A. L., Heywood, S. E., & Kingwell, B. A. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00258 · Cited by 97
Self-citationHDL and type 2 diabetes: the chicken or the egg?
Xepapadaki, E., Nikdima, I., Sagiadinou, E. C., Zvintzou, E., & Kypreos, K. E. (2021) · Diabetologia · doi:10.1007/s00125-021-05509-0 · Cited by 89
The Role of High-Density Lipoproteins in Diabetes and Its Vascular Complications
Wong, N. K. P., Nicholls, S. J., Tan, J. T. M., & Bursill, C. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061680 · Cited by 77
Arslanian, S. A., Kim, J. Y., Nasr, A., Bacha, F. F., Tfayli, H. M., Lee, S., & Toledo, F. G. S. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12562 · Cited by 82
Li, M., Zhang, W., Zhang, M., Li, L., Wang, D., Yan, G., Qiao, Y., & Tang, C. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-023-02103-z · Cited by 80
Pranata, R., Huang, I., Irvan, I., Lim, M. A., & Vania, R. (2021) · Endocrine · doi:10.1007/s12020-021-02780-4 · Cited by 76
Endoplasmic reticulum stress impairs cholesterol efflux and synthesis in hepatic cells
Röhrl, C., Eigner, K., Winter, K. S., Korbelius, M., Obrowsky, S., Kratky, D., Kovacs, W. J., & Stangl, H. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m043299 · Cited by 73
HDL Cholesterol and Non-Cardiovascular Disease: A Narrative Review
Kjeldsen, E. W., Nordestgaard, L. T., & Frikke‐Schmidt, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094547 · Cited by 76
Siebel, A. L., Natoli, A. K., Yap, F. Y. T., Carey, A. L., Reddy-Luthmoodoo, M., Sviridov, D., Weber, C. I. K., Meneses‐Lorente, G., Maugeais, C., Forbes, J. M., et al. (2013) · Circulation Research · doi:10.1161/circresaha.113.300689 · Cited by 71
Self-citationBabiker, R. A., Elmusharaf, K., Keogh, M. B., & Saeed, A. M. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0711-y · Cited by 69
Triglycerides/HDL cholesterol ratio and type 2 diabetes incidence: Panasonic Cohort Study 10
Yuge, H., Okada, H., Hamaguchi, M., Kurogi, K., Murata, H., Ito, M., & Fukui, M. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-02046-5 · Cited by 68
HDL-C and HDL-C/ApoA-I Predict Long-Term Progression of Glycemia in Established Type 2 Diabetes
Waldman, B., Jenkins, A. J., Davis, T. M. E., Taskinen, M., Scott, R. S., O'Connell, R. L., Gebski, V., Ng, M., & KEECH, A. C. (2014) · Diabetes Care · doi:10.2337/dc13-2738 · Cited by 69
Rethinking good cholesterol: a clinicians' guide to understanding HDL
Xiang, A. S., & Kingwell, B. A. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30003-8 · Cited by 70
Self-citationHDL-Cholesterol, Its Variability, and the Risk of Diabetes: A Nationwide Population-Based Study
Lee, S., Kim, H., Park, Y., Kwon, H., Yoon, K., Han, K., & Kim, M. K. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01080 · Cited by 66
Sokooti, S., Flores-Guerrero, J. L., Heerspink, H. J. L., Connelly, M. A., Bakker, S. J. L., & Dullaart, R. P. F. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01348-w · Cited by 69
Dietary guidelines for saturated fatty acids are not supported by the evidence
Parodi, P. W. (2015) · International Dairy Journal · doi:10.1016/j.idairyj.2015.08.007 · Cited by 69
Glucose and Lipid Dysmetabolism in a Rat Model of Prediabetes Induced by a High-Sucrose Diet
Burgeiro, A., Cerqueira, M., Varela-Rodríguez, B. M., Nunes, S., Neto, P., Pereira, F. C., Reis, F., & Carvalho, E. (2017) · Nutrients · doi:10.3390/nu9060638 · Cited by 73
Tang, S., Tabet, F., Cochran, B. J., Torres, L., Wu, B. J., Barter, P. J., & Rye, K. (2019) · Scientific Reports · doi:10.1038/s41598-018-38014-3 · Cited by 70
Self-citationHDL cholesterol and ASCVD risk stratification: A debate
Barter, P. J., & Genest, J. J. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.01.001 · Cited by 68
Self-citationNie, Q., Xing, M., Chen, H., Hu, J., & Nie, S. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b03430 · Cited by 65
Cochran, B. J., Bisoendial, R. J., Hou, L., Glaros, E. N., Rossy, J., Thomas, S. R., Barter, P. J., & Rye, K.-A. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304131 · Cited by 66
Self-citationSimonsen, J. B. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.05.009 · Cited by 64
HDL Particle Subspecies and Their Association With Incident Type 2 Diabetes: The PREVEND Study
Sokooti, S., Flores-Guerrero, J. L., Kieneker, L. M., Heerspink, H. J. L., Connelly, M. A., Bakker, S. J. L., & Dullaart, R. P. F. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab075 · Cited by 63
The effect of short‐term overfeeding on serum lipids in healthy humans
Heilbronn, L. K., Coster, A. C. F., Campbell, L. V., Greenfield, J. R., Lange, K. M., Christopher, M., Meikle, P. J., & Samocha‐Bonet, D. (2013) · Obesity · doi:10.1002/oby.20508 · Cited by 62
Future of High-Density Lipoprotein Infusion Therapies
Kingwell, B. A., & Chapman, M. J. (2013) · Circulation · doi:10.1161/circulationaha.113.002683 · Cited by 65
Self-citationCheng, C., Liu, Y., Sun, X., Yin, Z., Li, H., Zhang, M., Zhang, D., Wang, B., Ren, Y., Zhao, Y., et al. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12836 · Cited by 60
Adetunji, C. O., Michael, O. S., Rathee, S., Singh, K. R., Ajayi, O. O., Adetunji, J. B., Ojha, A., Singh, J., & Singh, R. P. (2021) · Materials Today Advances · doi:10.1016/j.mtadv.2021.100198 · Cited by 62
Wang, Y., Koh, W., Talaei, M., Yuan, J., & Pan, A. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12477 · Cited by 57
Role of HDL in Those with Diabetes
Santos‐Gallego, C. G., & Rosenson, R. S. (2014) · Current Cardiology Reports · doi:10.1007/s11886-014-0512-5 · Cited by 59
HDLs, Diabetes, and Metabolic Syndrome
Vollenweider, P., von Eckardstein, A., & Widmann, C. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-09665-0_12 · Cited by 55
Discoidal HDL and apoA-I-derived peptides improve glucose uptake in skeletal muscle
Dalla‐Riva, J., Stenkula, K. G., Petrlová, J., & Lagerstedt, J. O. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m032904 · Cited by 54
HDL cholesterol concentration or HDL function: which matters?
Barter, P. J., & Rye, K. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx274 · Cited by 54
Self-citationA Mendelian Randomization Study of Metabolite Profiles, Fasting Glucose, and Type 2 Diabetes
Liu, J., van Klinken, J. B., Semiz, S., van Dijk, K. W., Verhoeven, A., Hankemeier, T., Harms, A. C., Sijbrands, E. J. G., Sheehan, N. A., van Duijn, C. M., et al. (2017) · Diabetes · doi:10.2337/db17-0199 · Cited by 50
Advances in high-density lipoprotein physiology: surprises, overturns, and promises
Constantinou, C., Karavia, E. A., Xepapadaki, E., Πετροπούλου, Π.-Ι., Παπακώστα, Ε., Karavyraki, M., Zvintzou, E., Theodoropoulos, V., Filou, S., Hatziri, A., et al. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00429.2015 · Cited by 48
Fritzen, A. M., Domingo‐Espín, J., Lundsgaard, A., Kleinert, M., Israelsen, I. M. E., Carl, C. S., Nicolaisen, T. S., Kjøbsted, R., Jeppesen, J. F., Wojtaszewski, J. F. P., et al. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.01.013 · Cited by 49
Hirschler, V., Maccallini, G., Sanchez, M. S., González, C. D., & Molinari, C. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12228 · Cited by 48
Siebel, A. L., Trinh, S. K., Formosa, M. F., Mundra, P. A., Natoli, A. K., Reddy-Luthmoodoo, M., Huynh, K., Khan, A. A., Carey, A. L., van Hall, G., et al. (2016) · Metabolism · doi:10.1016/j.metabol.2016.03.002 · Cited by 47
Self-citationBonilha, I., Zimetti, F., Zanotti, I., Papotti, B., & Sposito, A. C. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112233 · Cited by 48
High-density lipoprotein and inflammation in cardiovascular disease
Connelly, M. A., SHALAUROVA, I. Y., & Otvos, J. D. (2016) · Translational research · doi:10.1016/j.trsl.2016.01.006 · Cited by 46
Bardagjy, A. S., & Steinberg, F. M. (2019) · Nutrients · doi:10.3390/nu11061231 · Cited by 48
Progression of insulin resistance: A link between risk factors and the incidence of diabetes
Wu, W.-C., Wei, J., Chen, S., Fan, K., Lin, C., Yang, C., Lin, M., Shih, S., Hua, C., Hsein, Y.-C., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108050 · Cited by 47
Zheng, D., Li, H., Ai, F., Sun, F., Singh, M., Cao, X., Jiang, J., He, Y., Tang, Z., & Guo, X. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000811 · Cited by 45
Chapman, M. J., Orsoni, A., Robillard, P., Hounslow, N. J., Sponseller, C. A., & Giral, P. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.874989 · Cited by 44
The effect of CETP inhibitors on new-onset diabetes: a systematic review and meta-analysis
Dangas, K., Navar, A.-M., & Kastelein, J. J. P. (2022) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvac025 · Cited by 44
HDL-Cholesterol and Triglycerides Dynamics: Essential Players in Metabolic Syndrome
Alcover, S., Ramos-Regalado, L., Girón, G., Muñoz‐García, N., & Vilahur, G. (2025) · Antioxidants · doi:10.3390/antiox14040434 · Cited by 50
Obafemi, T. O., Jaiyesimi, K. F., Olomola, A. A., Olasehinde, O. R., Olaoye, O. A., Adewumi, F. D., Afolabi, B. A., Adewale, O. B., Akintayo, C. O., & Ojo, O. A. (2021) · Toxicology Reports · doi:10.1016/j.toxrep.2021.07.011 · Cited by 40
Apolipoprotein A-I Protects Against Pregnancy-Induced Insulin Resistance in Rats
Wu, B. J., Sun, Y., Ong, K. L., Li, Y., Tang, S., Barter, P. J., & Rye, K. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.312282 · Cited by 39
Self-citationAnti-inflammatory Function of High-Density Lipoproteins via Autophagy of IκB Kinase
Gerster, R., Eloranta, J. J., Hausmann, M., Ruiz, P. A., Cosín‐Roger, J., Terhalle, A., Ziegler, U., Kullak-Ublick, G. A., von Eckardstein, A., & Rogler, G. (2014) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2014.12.006 · Cited by 45
Mak, J. K. L., Pham, N. M., Lee, A. H., Tang, L., Pan, X., Binns, C. W., & Sun, X. (2018) · Nutrition Journal · doi:10.1186/s12937-018-0413-3 · Cited by 44
Zhang, J., Suo, Y., Wang, L., Liu, D., Jia, Y. X., Fu, Y., Fan, W., & Jiang, Y. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02341-9 · Cited by 37
Tabara, Y., Arai, H., Hirao, Y., Takahashi, Y., Setoh, K., Kawaguchi, T., Kosugi, S., Ito, Y., Nakayama, T., & Matsuda, F. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.03.018 · Cited by 37
Nemecz, M., Stefan, D. S., Comariţa, I. K., Constantin, A. L., Tanko, G., Guja, C., & Georgescu, A. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01988-0 · Cited by 36
Salcedo-Cifuentes, M., Belalcazar, S., Acosta, E., & Medina-Murillo, J. J. (2019) · Archivos de Medicina (Manizales) · doi:10.30554/archmed.20.1.3534.2020 · Cited by 36
Frank, L. K., Jannasch, F., Kröger, J., Bedu‐Addo, G., Mockenhaupt, F. P., Schulze, M. B., & Danquah, I. (2015) · Nutrients · doi:10.3390/nu7075233 · Cited by 37
Therapeutic Approaches to the Regulation of Metabolism of High-Density Lipoprotein
Zhang, B., Kawachi, E., Miura, S.-I., Uehara, Y., Matsunaga, A., Kuroki, M., & Saku, K. (2013) · Circulation Journal · doi:10.1253/circj.cj-12-1584 · Cited by 34
Residual risks and evolving atherosclerotic plaques
Noothi, S. K., Ahmed, M. R., & Agrawal, D. K. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04689-0 · Cited by 37
Cochran, B. J., Ryder, W. J., Parmar, A., Tang, S., Reilhac, A., Arthur, A., Charil, A., Hamze, H., Barter, P. J., Kritharides, L., et al. (2016) · Diabetologia · doi:10.1007/s00125-016-3993-5 · Cited by 34
Self-citationAroner, S. A., Yang, M., Li, J., Furtado, J. D., Sacks, F. M., Tjønneland, A. M., Overvad, K., Cai, T., & Jensen, M. K. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx143 · Cited by 34
Fiorentino, T. V., Succurro, E., Marini, M. A., Pedace, E., Andreozzi, F., Perticone, M., Sciacqua, A., Perticone, F., & Sesti, G. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3289 · Cited by 33
Tong, X., Lv, P., Mathew, A. V., Liu, D., Niu, C., Wang, Y., Liang, J., Li, J., Fu, Z., Pan, B., et al. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-82 · Cited by 33
Owei, I., UMEKWE, N. A., Wan, J. Y., & Dagogo-Jack, S. E. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216659946 · Cited by 33
You, Y., Hu, H., Cao, C., Han, Y. Y., Tang, J., & Zhao, W. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1153072 · Cited by 34
Reyes‐López, R., Pérez-Luque, E. L., & Malacara, J. M. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2538 · Cited by 31
Plochberger, B., Röhrl, C., Preiner, J., Rankl, C., Brameshuber, M. O., Madl, J., Bittman, R., Ros, R., Sezgin, E., Eggeling, C., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-15949-7 · Cited by 32
Statins and New-Onset Diabetes
Barylski, M., Nikolić, D., Banach, M., Toth, P. P., Montalto, G., & Rizzo, M. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660678 · Cited by 30
Oswal, N., Lizardo, K., Dhanyalayam, D., Ayyappan, J. P., Thangavel, H., Heysell, S. K., & Nagajyothi, J. F. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11061646 · Cited by 29
ABCA1 agonist peptides for the treatment of disease
Bielicki, J. K. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000258 · Cited by 29
Cholesterol reprograms glucose and lipid metabolism to promote proliferation in colon cancer cells
Mayengbam, S. S., Singh, A., Yaduvanshi, H., Bhati, F. K., Deshmukh, B., Athavale, D., Ramteke, P. L., & Bhat, M. K. (2023) · Cancer & Metabolism · doi:10.1186/s40170-023-00315-1 · Cited by 28
The evolving role of cholesteryl ester transfer protein inhibition beyond cardiovascular disease
Mehta, N. N., Dangas, K., Ditmarsch, M., Rensen, P. C. N., Dicklin, M. R., & Kastelein, J. J. P. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106972 · Cited by 28
Zhao, D., Yang, L., Wang, X., Yuan, S., Yu, C., Wang, Z., Lang, J., & Feng, Y. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0450-1 · Cited by 28
Apolipoprotein Mimetic Peptides: An Emerging Therapy against Diabetic Inflammation and Dyslipidemia
Wolkowicz, P. E., White, C. R., & Anantharamaiah, G. M. (2021) · Biomolecules · doi:10.3390/biom11050627 · Cited by 29
Aroner, S. A., Furtado, J. D., Sacks, F. M., Tsai, M. Y., Mukamal, K. J., McClelland, R. L., & Jensen, M. K. (2019) · Diabetologia · doi:10.1007/s00125-019-4847-8 · Cited by 27
Metadata
- Authors
- Drew, B. G., Rye, K.-A., Duffy, S. J., Barter, P., & Kingwell, B. A.
- Affiliations
- Baker Heart and Diabetes Institute (AU)
- The Heart Research Institute (AU)
- The Alfred Hospital (AU)
- Corresponding author
- Kingwell, Bronwyn A.
- Venue
- Nature Reviews Endocrinology
- Published
- 2012-01-24
- Volume
- 8
- Issue
- 4
- Pages
- 237-245
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- OpenAlex
- W1982981124
- Cited by
- 307
- References
- 114
- Citations by year
- 2026: 14 · 2025: 33 · 2024: 36 · 2023: 29 · 2022: 24 · 2021: 23 · 2020: 16 · 2019: 18 · 2018: 14 · 2017: 22 · 2016: 19 · 2015: 15 · 2014: 21 · 2013: 16 · 2012: 6
- FWCI
- 2.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Reviews Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- State Government of Victoria
- National Health and Medical Research Council
- National Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- high-density lipoprotein, glucose metabolism, glucose homeostasis, type 2 diabetes, insulin secretion, AMPK, muscle glucose uptake, insulin sensitivity, CETP inhibitors, HDL-raising therapy, atherosclerosis, lipid removal
- MeSH terms
- Animals, Blood Glucose, Diabetes Mellitus, Type 2, Humans, Insulin, Lipoproteins, HDL, Cholesterol, HDL
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review